Quantalan

Quick links to important sections

Quantalan

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Quantalan

Quick Facts

Property Description
Active ingredient Colestyramine resin (Cholestyramine)
Form Powder for oral suspension
Pharmacological class Bile Acid Sequestrant (BAS)
Common use Reduction of high LDL cholesterol; relief of pruritus
Origin Synthetic polymer (anion-exchange resin)

What Type of Medicine is Quantalan (Colestyramine)?

Quantalan is a prescription-only medicine with the active ingredient Colestyramine resin (INN: Colestyramine). It is officially classified as a Bile Acid Sequestrant (BAS) and is used as an adjunctive treatment for elevated blood lipids, particularly high low-density lipoprotein (LDL) cholesterol. This classification places it within the broader group of hypolipidemic agents. Unlike other cholesterol therapies that are absorbed, this drug is structurally unique as a non-absorbed synthetic polymer designed for localized action in the gastrointestinal tract. Pharmacological studies support its effectiveness when used as part of a complete program involving diet and exercise.


Composition, Origin, and Dosage Form

The active component, Colestyramine resin, is a synthetic polymer that functions chemically as a strongly basic anion-exchange resin. It is insoluble and passes through the digestive system without being absorbed, which is a key distinguishing feature from most oral medications. Quantalan is supplied as a fine granular powder for oral suspension and is a single-ingredient product. This specific powdered form, which must be mixed with water or other suitable liquids or soft foods, is essential for its function, allowing it to disperse effectively throughout the small intestine to maximize its binding capacity.


Quantalan's General Purpose: Cholesterol Reduction and Pruritus Relief

The primary general purpose of Quantalan is to assist in the reduction of high levels of LDL cholesterol by interrupting the natural recycling of bile acids. The resin binds irreversibly to bile acids in the intestine, leading to their removal via stool. By forcing the body to use existing cholesterol to produce new bile acids, the concentration of LDL cholesterol in the bloodstream is lowered. Furthermore, the effectiveness of Colestyramine in reducing serum bile acid levels is clinically recognized for providing relief from the intense itching (pruritus) that can be associated with partial liver or gallbladder conditions.

Regulatory References

  1. Cholestyramine Resin: MedlinePlus Drug Information
  2. Drug treatment of pruritus in liver diseases - NIH

What side effects are possible with Quantalan?

Possible side effects and safety information

The officially documented safety profile of Colestyramine resin, the active ingredient in Quantalan, reflects its primary localized action in the gastrointestinal tract and secondary systemic effects resulting from altered absorption.

Adverse Reaction Scope

The most commonly reported adverse reactions are centered on the digestive system. Regulatory classifications define constipation as a Very Common effect (occurring in 10% or more of patients), which is the principal safety characteristic listed in official prescribing information.

Less frequent adverse reactions are often linked to the interference with absorption. These may include the development of hyperchloremic acidosis and deficiencies of fat-soluble vitamins, specifically Vitamin A, D, and K, which can, in turn, lead to bleeding tendencies due to hypoprothrombinemia.

Classification Examples of Adverse Reactions (SOC)
Gastrointestinal (Very Common) Constipation, abdominal discomfort, flatulence, nausea, vomiting, steatorrhea
Metabolic (Uncommon) Hyperchloremic acidosis, Vitamin A/D/K deficiencies
Musculoskeletal (Common/Uncommon) Osteoporosis, joint or muscle pain

Serious Adverse Reactions and Safety Constraints

Official regulatory sources document Intestinal obstruction as a rare but serious adverse reaction, with reports including pediatric patients. Bleeding tendencies resulting from Vitamin K deficiency are also considered clinically significant.

Specific safety constraints are defined in the labeling. The medicine is contraindicated in individuals with a complete biliary obstruction. Safety notes also indicate that the incidence of constipation is associated with high dose and increased age (over 60 years), and that prolonged use is associated with a greater risk of nutritional deficiency effects.

Additionally, patients with renal impairment are at an increased risk of developing hyperchloremic metabolic acidosis, a population-specific safety consideration formally documented in prescribing information.

Overdose and Emergency Response

Quantalan Overdose and When to Seek Help

Official regulatory documents describe the overdose profile for Quantalan based on its physical properties, as no human data on acute overdose is available.

Primary Overdose Risk

Quantalan is an inert, water-insoluble resin that is not absorbed into the body from the gastrointestinal (GI) tract. Consequently, the primary concern following an acute overdose is not systemic toxicity, but the risk of complete or partial gastrointestinal tract obstruction.

Overdose symptoms would be related to this mechanical blockage, such as severe abdominal pain, nausea, vomiting, or the inability to pass gas or stool.

Emergency Actions and Treatment

Immediate medical attention must be sought for any suspected overdose. This is essential to quickly assess for and manage potential GI tract obstruction, which is a serious medical condition.

Overdose Component Official Regulatory Status
Anticipated Symptoms Symptoms due to GI tract obstruction
Systemic Toxicity Risk Not a primary concern; drug is not absorbed
Known Antidote None specified
Recommended Treatment Symptomatic and supportive care

Since no specific antidote is known for Quantalan, medical management focuses on symptomatic and supportive care to stabilize the patient and address the risk of mechanical obstruction.

Therapeutic Uses of Quantalan

Quick Facts

  • May assist in lowering: Elevated levels of low-density lipoprotein (LDL) cholesterol in the bloodstream.
  • May help manage: Itching (pruritus) associated with incomplete obstruction of the bile ducts.

Quantalan is a prescription medication utilized as an adjunctive treatment, supporting dietary changes, to help manage specific medical conditions. Its primary use is in providing support for the reduction of elevated serum cholesterol, specifically in patients who have primary hypercholesterolemia with high LDL cholesterol and have not responded adequately to dietary intervention alone. Reducing high cholesterol levels is an established part of a comprehensive program to help lower the risk of cardiovascular concerns.

The medication may also be used to help achieve symptom relief from pruritus, or severe itching, that can occur when there is a partial or incomplete blockage of the bile ducts. In this context, Quantalan helps to support the clearance of excess bile acids from the system, which is thought to be the cause of the itching.

Eligibility and Restrictions for Use

Who can and cannot use Quantalan?

Eligibility for Quantalan (Colestyramine resin) is defined by official regulatory documentation, which outlines absolute non-eligibility and conditional use based on patient status and co-existing conditions.

Contraindications: Who Must Not Use

The medicine is contraindicated in two primary patient populations:

  • Individuals with a complete biliary obstruction where bile does not enter the intestine, as the medicine's mechanism requires bile presence.
  • Individuals with a known hypersensitivity (allergy) to Colestyramine resin or any other component in the formulation.

Age and Condition Restrictions

Population Group Regulatory Status Restriction Context (Official Labeling)
Children under 6 years Use Not Established Efficacy and safety have not been adequately established for this age group [Source 2.4].
High Triglycerides Not Recommended Use is not indicated if baseline fasting triglyceride levels are ge 300 mg/dL [Source 2.1].
Renal Impairment Use with Caution Potential for hyperchloremic acidosis (electrolyte disturbance) requires caution and monitoring [Source 2.3].
Pregnancy/Lactation Conditional Non-systemic absorption makes it acceptable in lactation; use during pregnancy requires weighing benefits against the risk of maternal fat-soluble vitamin deficiency [Source 4.1].

Eligibility also requires that secondary causes of hypercholesterolemia (such as an underactive thyroid) be ruled out or corrected before starting therapy [Source 4.2]. Additionally, patients with pre-existing constipation require caution due to the risk of aggravation [Source 2.1].

What should I know about interactions with other medicines?

Interactions with other medicines and products

Quantalan (Colestyramine) is a non-absorbed resin, and its official interaction profile is dominated by physicochemical binding in the gastrointestinal tract, a pharmacokinetic interaction that reduces the systemic exposure of co-administered oral agents. This requires specific administration constraints documented in regulatory labeling.

Timing and Absorption Requirements

To minimize the reduction in drug absorption, other oral medications must be administered at least 1 hour before or 4 to 6 hours after Colestyramine. Medications affected by this absorption-reducing effect include Thyroid Hormones (e.g., Levothyroxine), Digitalis/Cardiac Glycosides (e.g., Digoxin), Thiazide Diuretics, and certain Statins.

Pharmacodynamic and Nutrient Interactions

Chronic use may interfere with the absorption of fat-soluble vitamins (A, D, E, K) and Folic acid. This can lead to Vitamin K deficiency (hypoprothrombinaemia), which is a significant pharmacodynamic interaction when co-administered with Warfarin or other oral anticoagulants, potentially increasing bleeding risk. Co-administration with Spironolactone is noted for an increased potential for hyperchloraemic acidosis, particularly in susceptible populations.

Formal Restrictions

Quantalan is officially contraindicated in the disease state of complete biliary obstruction. The sugar-free formulation contains phenylalanine and must be considered a restriction for patients with Phenylketonuria (PKU). The risk of acidosis is increased in younger patients and those with renal impairment.

Mechanism of Action

Interruption of Enterohepatic Circulation

The mechanism of Quantalan involves localized chemical sequestration in the gastrointestinal tract. As a non-absorbed anion-exchange resin, the drug binds tightly to negatively charged bile acids, forming an insoluble complex that prevents their normal reabsorption from the small intestine back to the liver. This action creates an artificial drain on the body's bile acid pool by increasing their fecal excretion, thus interrupting the enterohepatic recycling pathway .


⬆️ Cascade Effect on LDL-C Clearance

The continuous loss of bile acids forces the liver to synthesize new ones, requiring it to consume its existing hepatic cholesterol supply. This depletion of intracellular cholesterol triggers a regulatory feedback mechanism: the upregulation of LDL receptors on the liver cell surface. These receptors increase the rate at which low-density lipoprotein cholesterol (LDL-C) is scavenged from the plasma and metabolized by the liver. This mechanistic cascade results in the primary physiological consequence of enhanced LDL-C clearance.


⬇️ Reduction of Systemic Bile Acid Pool

Beyond lipid modulation, the sequestration mechanism also leads to a reduction in the total body pool of bile acids. By forcing their excretion, Quantalan lowers the concentration of bile acids circulating in the plasma. This reduction in the systemic serum bile acid pool is the physiological change that influences the deposition of pruritogenic compounds in peripheral tissues.

Dosage and Administration Information

How to Use Quantalan: Administration Guidelines

Quantalan (Colestyramine resin) is administered exclusively via the oral route as a powder for suspension, which is mandatory due to the medication’s chemical properties and potential administration hazards when taken dry.

Preparation and Timing Requirements

The powder must never be consumed in its dry form. Each dose, typically containing 4 grams of the anhydrous resin, is to be thoroughly mixed with approximately 60 to 180 mL (2 to 6 ounces) of a non-carbonated liquid or soft, pulpy food before ingestion. The medication may be taken at mealtimes or at bedtime.

A critical requirement for its proper use is the timing separation from other medicines. To prevent potential impaired absorption, any other oral medication must be administered at least one hour before or four to six hours after Quantalan.

Dosing Regimens

The standard adult treatment initiates with a dose of 4 grams once or twice daily. The total daily dosage is generally maintained between 8 grams and 16 grams, divided into two to four daily doses, which is determined by clinical needs and response to therapy. The maximum daily dose is typically 24 grams of Colestyramine resin.

For pediatric patients (6–12 years), the dose is calculated based on body weight, using a maximum of 240 mg/kg/day of the resin, divided into two or three doses, with a total dose not usually exceeding 8 grams daily.

Duration and Adjustment

Treatment with Quantalan is typically long-term to sustain its effect. Dose adjustments, if necessary, are based on the results of periodic clinical assessments and are generally not implemented at intervals shorter than four weeks.

Recent Clinical Evidence

Research evidence / Overview of studies for Quantalan

Research Examining High LDL Cholesterol

The foundational research for Quantalan's role in cholesterol management is based on large-scale, long-term randomized, placebo-controlled trials (RCTs). These studies tracked participants over many years to examine whether the treatment, combined with diet, was observed in two areas: measurements of Low-Density Lipoprotein (LDL) cholesterol levels, and the occurrence of cardiovascular events (such as a composite of Coronary Heart Disease death and non-fatal myocardial infarction). Findings describe patterns where the treated group and the placebo group recorded differences in the occurrence rate of the composite endpoint. The research provides context on how this medication was evaluated against an inactive treatment and background dietary management.


Research Examining Itching (Pruritus)

The evidence base for addressing intense itching, or pruritus, associated with impaired bile flow consists primarily of smaller, short-term, randomized studies and systematic reviews. Research explored the use of Colestyramine in contexts involving functional imbalance, examining changes in symptom intensity using patient-reported tools. Evidence remains limited and heterogeneous across this indication; findings were mixed, and all reported outcomes are short-term, typically covering only a few weeks of observation.


Study Duration, Subgroups, and Uncertainty

The main prevention trial for cholesterol management had an extended follow-up duration of 7.4 years, allowing research to describe the evolution of outcomes over a significant time span. However, the foundational research was conducted almost exclusively on asymptomatic middle-aged men. Consequently, data for groups like women and older adults remain insufficient in the context of the main clinical endpoint trials. While Colestyramine was evaluated in research exploring its use in children with inherited forms of high cholesterol, the evidence quality for pruritus is generally limited by small sample sizes, and subgroup findings are uncertain for many broader patient segments.

Frequently Asked Questions (FAQ)

Common questions about Quantalan (FAQ)

Q: Is Quantalan used for anything besides its primary stated condition?

A: Official medical literature indicates that Quantalan is studied and sometimes used for managing bile-acid diarrhea. It may also be mentioned as an adjunctive treatment for conditions like thyrotoxicosis or to help the body eliminate certain medications. The primary authorized uses, however, remain high cholesterol and pruritus relief.

Q: How quickly do people typically start to notice the effect of Quantalan?

A: Clinical data suggests that the maximal reduction in LDL cholesterol levels is often achieved after approximately two weeks of consistent therapy. If the medication is being taken for itching (pruritus), official sources suggest the symptomatic relief may occur more rapidly.

Q: Is it common to feel tired after starting Quantalan?

A: Patient information derived from official labeling notes that feelings of weakness or tiredness have been reported as common side effects. This information may be useful to note when consulting with a healthcare provider.

Q: Can Quantalan cause weight changes?

A: Official prescribing information indicates that excess body weight may be a condition to address prior to starting this type of therapy. However, the medication's labeling does not explicitly list weight gain or weight loss as a reported side effect of the drug itself.

Q: Is Quantalan safe to use if I have high blood pressure?

A: Official drug information describes a potential interaction between Quantalan and certain diuretics (water pills) used to manage high blood pressure. If diuretics are being used, healthcare providers often consider adjustments to medication timing to prevent impaired absorption.

Q: Can Quantalan be taken with cold and flu medicine?

A: The regulatory guidelines emphasize that Quantalan's binding mechanism can reduce the absorption of many other oral medications. This includes over-the-counter drugs like cold and flu medicines. To minimize this, official sources recommend taking any other oral medicine at least one hour before or four to six hours after Quantalan.

Q: Is it true that Quantalan has been studied for condition Z?

A: Research has explored the use of the drug's active ingredient in managing certain aspects of type 2 diabetes mellitus, specifically looking at its effects on glucose levels. Furthermore, the drug is used for treating bile-acid diarrhea, which goes beyond its primary cholesterol-lowering use.

Q: What should I do if I experience a strange side effect from Quantalan?

A: Official health information states that individuals should contact their healthcare provider if they experience any unexpected or concerning side effects. Additionally, in the United States, patients and providers have the option to voluntarily report side effects to the FDA's MedWatch program.

Q: Does Quantalan interact with herbal supplements?

A: While the drug's binding interaction is primarily tested with prescription medications, the mechanism suggests that herbal products could also be affected. Regulatory guidance advises informing your healthcare provider about all supplements and herbal products you take to ensure proper use.

Q: Are there any specific foods or drinks to avoid while taking Quantalan?

A: Official drug information indicates that there are no specific foods or drinks that are known to interfere with the medication's action. The only requirement is that the powder must be thoroughly mixed with a non-carbonated liquid or soft food, such as applesauce, before it is ingested.

Q: Is Quantalan considered a controlled substance?

A: The active ingredient in Quantalan is not classified as a controlled substance under U.S. federal regulations. It is a prescription-only medication but is not subject to the scheduling requirements for controlled substances.

Q: How long does Quantalan stay in your system after stopping it?

A: Quantalan is designed as a non-absorbed resin, meaning it does not enter the bloodstream and is not metabolized by the body. Once it passes through the gastrointestinal tract, the drug is excreted entirely in the feces shortly after use.

Q: Why do official documents mention that Quantalan is not suitable for children?

A: Official labeling states that the safety and effectiveness of the drug have not been established for all pediatric age groups, specifically in children under six years old. The determination of suitability for children is based on whether adequate efficacy and safety data exist for that population.

Q: Does Quantalan interact with alcohol?

A: There are no specific documented direct interactions between the drug and alcohol. However, alcohol consumption is a known factor that can affect cholesterol levels, and combining it with the drug could theoretically increase the risk of bleeding if the patient develops Vitamin K deficiency.

Q: Can elderly patients take Quantalan?

A: Yes, the medication may be used in elderly patients, but regulatory documents note that those over 60 years of age may be more sensitive to the drug's effects. Specifically, the occurrence of constipation is noted as being associated with increased age.

Q: Is Quantalan a new drug, or has it been around for a while?

A: Quantalan is considered one of the older cholesterol-lowering medications, as its active ingredient was first approved by the U.S. Food and Drug Administration (FDA) in 1973. This makes it one of the longest-used treatments in its pharmacological class.

Q: What are the possible risks for people with liver problems taking Quantalan?

A: Regulatory data indicates that while the drug is sometimes used in chronic liver conditions to manage itching, it may cause mild and temporary elevations in certain serum liver enzymes. However, this is generally not associated with severe liver damage. It remains strictly contraindicated in cases of complete biliary obstruction.

Q: Does Quantalan have a generic equivalent?

A: Yes, the active ingredient, Cholestyramine resin, is available as a generic drug. It is also marketed under various brand names in addition to Quantalan.

Q: What are the signs of a possible allergic reaction to Quantalan?

A: Official documentation mentions that a hypersensitivity (allergic) reaction is a contraindication to use. Signs of a severe reaction may include difficulty breathing, wheezing, or shortness of breath.

Q: Can I take Quantalan if I am sensitive to other similar medications?

A: Regulatory information advises that the medication should not be used if there is a known allergy or sensitivity to bile-sequestering resins or to any of the specific ingredients in the formulation. This classification is a key element of the eligibility criteria.

Q: What official body approved Quantalan for its current use?

A: The drug's initial authorization for use in the United States was granted by the Food and Drug Administration (FDA). This government agency sets the standards for drug use and safety within the U.S.

Q: Is it normal to have mild headaches when starting Quantalan?

A: Headache is listed in the clinical literature as a possible symptom that can be associated with hyperchloremic acidosis, which is a potential electrolyte disturbance that may be caused by the drug.

Q: Does the effectiveness of Quantalan change over time?

A: Clinical studies that followed patients for extended periods (up to four years) described that the decreases in cholesterol levels were sustained throughout the duration of the study. Treatment is typically considered long-term to maintain the desired effect.

Q: Can Quantalan affect my mood or mental state?

A: Regulatory documentation lists confusion as a possible symptom related to hyperchloremic acidosis, a potential electrolyte imbalance that the medication can cause. Noting any changes in mental state may be helpful for consultation with a healthcare provider.

Q: Is Quantalan known to be hard on the kidneys?

A: The drug does not typically cause direct kidney damage, but it can increase the risk of developing an electrolyte imbalance called hyperchloremic acidosis. This risk is specifically noted to be higher for patients who already have kidney disease.

Q: Is Quantalan suitable for people who are physically active?

A: Official product information states that Quantalan is intended to be used as part of a complete treatment program that includes dietary adjustments and exercise. The labeling does not specify restrictions related to high levels of physical activity.

Q: Are there any warnings about stopping Quantalan suddenly?

A: Official regulatory notes indicate that if the medication is stopped, the body’s cholesterol levels could worsen again. If the drug is being used for itching (pruritus), that symptom may also return if treatment is discontinued.

Q: What does the patient leaflet for Quantalan say about its use in adolescents?

A: The prescribing information provides specific dosage guidance for pediatric patients, including adolescents. For individuals over the age of 12 years, the maximum dosage is typically defined as the same as the adult maximum dose.

Q: Does Quantalan carry any special precautions or warnings from the FDA?

A: Yes, the official labeling includes several special precautions. These include warnings about the potential risk of bleeding due to Vitamin K deficiency, intestinal obstruction, and the possibility of hyperchloremic acidosis (an electrolyte disturbance), especially for individuals with existing kidney problems.

Q: Is there a link between Quantalan and vision problems?

A: Official sources note that long-term use of the drug may interfere with the body's ability to absorb fat-soluble vitamins, including Vitamin A. Since Vitamin A is necessary for healthy vision, deficiency is a possible risk associated with chronic use.

How should Quantalan be stored and disposed of?

Storage and Disposal Requirements for Quantalan (Cholestyramine Resin)

Official labeling requires Quantalan to be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). The product must be protected from environmental factors like excessive heat, moisture, and must be kept from freezing to maintain its stability. It is mandatory to store the medicine in a tightly closed container and keep it out of the reach of children.

For disposal, unused or expired product must not be kept. Patients should follow official regulatory guidance, prioritizing community drug take-back programs. If a take-back program is not available, the medicine may be mixed with an undesirable substance (such as dirt) and placed in a sealed container before discarding in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Quantalan found in:

A-Z Index: